How will your role help us transform hope into reality?
Systemic Mastocytosis (SM) is a rare and underdiagnosed disease, where patients often suffer for years before receiving an accurate diagnosis. With AYVAKIT, the first and only treatment designed to target the root cause of SM, now available, we are transforming patient care in a space with true blockbuster potential.
The Field Marketing Team Leader plays a pivotal role in translating national brand strategy into regional execution. By leading and developing the national team of Regional Marketing Executives (RME) to excel as regional marketing partners, you will ensure the franchise’s strategic priorities are amplified locally, driving measurable impact across key centers, hubs, and influential customers. You will oversee efforts to foster today’s SM Champions while building the next wave of advocates & thought leaders, advance speaker & KOL engagement, drive long-term account & customer planning and serve as a strategic thought partner across the field & headquarters. This role is about shaping influence, accelerating adoption, and ensuring the RME team is a force multiplier for the franchise.
As a key member of the Marketing Leadership Team, reporting to the Vice President of Commercial Strategy and Marketing, you will collaborate with colleagues across headquarters and field leaders to bring national strategy to life locally and ensure progress is visible, measurable, and impactful. You will also contribute to cross-functional enterprise initiatives and change management efforts, helping shape brand strategy and execution excellence across the broader commercial organization.
Location is flexible, regular travel to customers, team visits and headquarters will be expected.
What will you do?
What minimum qualifications do we require?
What additional qualifications will make you a stronger candidate?
Why Blueprint?
At Blueprint Medicines, patients are our purpose. Their needs ignite our innovation, fuel our urgency and inspire us to go further - faster. We bet on bold people who want to grow, push boundaries and lead meaningful change. Here, you’ll do the most impactful work of your career - because our commitment to changing lives isn’t just what we do, it’s who we are.
Patients are waiting. Are you ready to make the leap?
Equal Employment Opportunity
At Blueprint Medicines, we foster an environment of fair treatment and full participation for all of our employees as we navigate complex challenges in pursuing our mission to improve the lives of patients. We celebrate our unique differences and varied career and life experiences so that we can sustain our diverse culture and ensure everyone feels accepted. We are committed to non-discrimination, equal employment opportunity, as well as an inclusive recruitment process. We consider all qualified applicants based on merit and without regard to race, color, sex, gender identity, sexual orientation, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, or any other characteristic protected under applicable federal or state law.
We will make reasonable accommodations, absent undue hardship, for qualified individuals with known disabilities. If you are an individual with a disability in need of an accommodation with the application or recruiting process, please reach out to TotalRewards@blueprintmedicines.com. We are also an E-Verify Employer. For more information, please see our EEO Policy Statement, the E-Verify Participation Poster, the Right to Work Poster, and/or the EEO Know Your Rights Poster.
Blueprint Medicines, a Sanofi company, is a global biopharmaceutical company that invents life-changing medicines. We seek to improve and extend patients' lives by solving important medical problems, with a focus on allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a track record of success with two approved medicines, including AYVAKIT/AYVAKYT (avapritinib) which we are bringing to patients with SM in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases and solid tumors. For more information, visit www.BlueprintMedicines.com and follow us on X (formerly Twitter; @BlueprintMeds) and LinkedIn_._